Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of a local anesthetic agent and tramadol hydrochloride, typically used in dental or minor surgical procedures to provide both anesthesia and analgesia. Tramadol hydrochloride acts as a centrally acting opioid analgesic with additional mechanisms including inhibition of serotonin and norepinephrine reuptake. When combined with a conventional local anesthetic (such as lidocaine) or vasoconstrictor agents like adrenaline, this formulation can enhance the duration and efficacy of anesthesia while providing postoperative pain relief. The mechanism involves both peripheral nerve blockade by the local anesthetic component and central/peripheral modulation of pain by tramadol through μ-opioid receptor agonism, serotonin reuptake inhibition, norepinephrine reuptake inhibition, sodium channel blockade, NMDA receptor antagonism, among others[2][3][5][7]. This combination is considered particularly useful when standard amide-type or ester-type local anesthetics are contraindicated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on local anesthetic + tramadol hydrochloride.